| ENOVIS CORP. |
| USA |
| Gesundheit |
| US1940145022 / A3DHHV |
| C520 (Frankfurt) / ENOV (NYSE) |
| FRA:C520, ETR:C520, C520:GR, NYSE:ENOV |
| - |
| https://enovis.com/ |
|
Enovis Corporation is a medical technology company focused on developing clinically differentiated solutions for musculoskeletal health. Enovis Corporation designs, manufactures, and distributes medical devices and services used across the patient ca..
>Volltext.. |
| 1021.83 Mio. EUR |
| 2194.37 Mio. EUR |
| 1982.11 Mio. EUR |
| 322.82 Mio. EUR |
| -949.4 Mio. EUR |
| -16.6 EUR |
| 1181.57 Mio. EUR |
| 10.84 Mio. EUR |
| 233.12 Mio. EUR |
| 0.02 |
| 4.89% |
| -32.92% |
| - |
| - |
| - |
| ENOVIS |
| 05.09.26 |